The hypothesis that the lungs could be the primary site of immune deregulation in RA is supported by the fact that there are increased inflammatory markers in the lungs of patients with early RA compared to healthy controls, as well as the increased citrullination of proteins in the lungs of both healthy smokers and early, untreated ACPA-positive RA patients. This evidence concerns the gene PRTN3 and rheumatoid arthritis.